Research Reports

Every report we've published, newest first.

NXTT

NXTT: The Anatomy of a Pump and Dump Disguised as a Bitcoin Play

Mar 25, 2026

Next Technology's spectacular collapse from $28 to $1.20 in three months reveals the brutal mechanics of dilution machines masquerading as bitcoin treasuries.

Read →
ITOC

ITOC Rockets 80% Pre-Market After $20M Private Placement at Big Discount

Mar 25, 2026

ITOC rockets 80% pre-market after announcing a $20M private placement at $0.20 per share, creating arbitrage dynamics and dilution risk for the beaten-down cancer treatment software play.

Read →
NUCL

NUCL Breaks Out 29% as Uranium Bulls Return — But Know the Dilution Risk

Mar 24, 2026

Eagle Nuclear explodes higher on sector momentum and permitting news, but small-cap uranium plays carry serious float expansion risks.

Read →
GOCO

GOCO: Dead Cat Bounce After Hitting All-Time Low - The Dilution Machine Still Running

Mar 24, 2026

GoHealth surged 22% Monday after touching $1.31 all-time lows in early March, but the rally masks deeper structural problems from massive dilution and deteriorating fundamentals.

Read →
RBNE

RBNE Rockets 87% on $3 Tender Offer: Buyback Signal or Value Trap?

Mar 24, 2026

Robin Energy explodes 87% on surprise $3 tender offer, creating potential arbitrage play but highlighting the risks of a serial dilution machine.

Read →
FEED

FEED Jumps 51% Pre-Market as ENvue Medical Expands Hospital Footprint, But Series H Conversion Overhang Looms

Mar 24, 2026

ENvue Medical surges on Detroit hospital deal expanding its feeding tube navigation platform to 39 hospitals, but Series H preferred shares create 800% dilution overhang.

Read →
PAVS

PAVS: The Dilution Machine Suddenly Stops — But Is Anyone Still Paying Attention?

Mar 24, 2026

PAVS jumped 93% after ending its share dilution program with AGP, but the mechanics suggest this is temporary relief rather than a fundamental turnaround.

Read →
PMAX

PMAX Explodes 29% on Boston Solar Deal — But Dilution Risk Remains Heavy

Mar 23, 2026

Powell Max caught fire on news of a $9M solar acquisition, but traders need to read between the lines on this micro-cap's cash-burning structure.

Read →
GMEX

GMEX Surges 35% on First Commercial Order — Understanding the Robotics Pivot

Mar 23, 2026

GMEX exploded 35% on its first commercial robotics order worth AU$4.2M — three times the company's market cap. Here's how the fitness-to-robotics transformation is playing out and what traders need to watch.

Read →
ZYBT

ZYBT Pops 19% But Dilution Hangover Remains From $14 High

Mar 23, 2026

ZYBT bounced hard off March 2nd's close but the Chinese vet vaccine maker still trades 94% below its April 2025 peak amid ongoing dilution concerns.

Read →
AHMA

AHMA: Travel Stock's 73% Surge Masks Corporate Governance Red Flags

Mar 23, 2026

AHMA's 73% surge on travel industry news masks serious governance restructuring and extreme valuations that suggest this momentum play carries significant risks.

Read →
UGRO

UGRO Explodes 74% in Pre-Market After Reverse-Split Squeeze Meets Flash Merger

Mar 23, 2026

UGRO ripped 74% to $3.79 in Sunday's pre-market session after a brutal 25:1 reverse split created massive mechanical pressure on what's now a minuscule 684K share float.

Read →